Increased plasma levels of NT-proBNP, Troponin T and GDF-15 are driven by persistent AF and associated comorbidities: Data from the AF-RISK study

Atrial fibrillation (AF) is a progressive disease, and early recognition and management may reflect an important strategy to reduce its disease burden. In this study, we evaluated plasma levels of three biomarkers - N-terminal pro-brain natriuretic peptide (NTproBNP), Troponin-T, and growth differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Meems, L.M.G., Artola Arita, V., Velt, M., Dudink, E.A.M.P., Crijns, H.J.G.M., Van Gelder, I.C., Rienstra, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914333/
https://www.ncbi.nlm.nih.gov/pubmed/35281756
http://dx.doi.org/10.1016/j.ijcha.2022.100987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914333/
https://www.ncbi.nlm.nih.gov/pubmed/35281756
http://dx.doi.org/10.1016/j.ijcha.2022.100987

Ejemplares similares